Margarita Shleeva

Dr. Margarita Shleeva

orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 July 2023 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
MSMargarita Shleeva
Margarita Shleeva
DKDaria A. Kondratieva
Daria A. Kondratieva
AKArseny Kaprelyants
Arseny Kaprelyants
Bacillus licheniformis produces several classes of antimicrobial substances, including bacteriocins, which are peptides or proteins with different structural composition and molecular mass: ribosomally synthesized by bacteria (1.4–20 kDa), non-ribosomally synthesized peptides and cyclic lipopeptides (0.8–42 kDa) and exopolysaccharides (>1000 kDa). Different bacteriocins act against Gram-positive or Gram-negative bacteria, fungal pathogens and amoeba cells. The main mechanisms of bacteriocin lytic activity include interaction of peptides with membranes of target cells resulting in structural alterations, pore-forming, and inhibition of cell wall biosynthesis. DNase and RNase activity for some bacteriocines are also postulated. Non-ribosomal peptides are synthesized by special non-ribosomal multimodular peptide synthetases and contain unnatural amino acids or fatty acids. Their harmful effect is due to their ability to form pores in biological membranes, destabilize lipid packaging, and disrupt the peptidoglycan layer. Lipopeptides, as biosurfactants, are able to destroy bacterial biofilms. Secreted polysaccharides are high molecular weight compounds, composed of repeated units of sugar moieties attached to a carrier lipid. Their antagonistic action was revealed in relation to bacteria, viruses, and fungi. Exopolysaccharides also inhibit the formation of biofilms by pathogenic bacteria and prevent their colonization on various surfaces. However, mechanism of the harmful effect for many secreted antibacterial substances remains unknown. The antimicrobial activity for most substances has been studied in vitro only, but some substances have been characterized in vivo and they have found practical applications in medicine and veterinary. The cyclic lipopeptides that have surfactant properties are used in some industries. In this review, special attention is paid to the antimycobacterials produced by B. licheniformis as a possible approach to combat multidrug-resistant and latent tuberculosis. In particular, licheniformins and bacitracins have shown strong antimycobacterial activity. However, the medical application of some antibacterials with promising in vitro antimycobacterial activity has been limited by their toxicity to animals and humans. As such, similar to the enhancement in the antimycobacterial activity of natural bacteriocins achieved using genetic engineering, the reduction in toxicity using the same approach appears feasible. The unique capability of B. licheniformis to synthesize and produce a range of different antibacterial compounds means that this organism can act as a natural universal vehicle for antibiotic substances in the form of probiotic cultures and strains to combat various types of pathogens, including mycobacteria.

8 September 2016 in FEMS Microbiology Letters
Verified
Journal Article
Open access
PDF file
VNV D Nikitushkin
V D Nikitushkin
MSMargarita Shleeva
Margarita Shleeva
AZAlexander Zinin
Alexander Zinin
KTKseniya Trutneva
Kseniya Trutneva
DOD N Ostrovsky
D N Ostrovsky
AKA S Kaprelyants
A S Kaprelyants
Upon transition of Mycobacterium smegmatis into the dormant state, accumulation of a dark brown fluorescent pigment was observed. This pigment gave bright red fluorescence in both cells and the culture medium. Based on 1H-NMR, MALDI and UV spectra, the fluorescent compounds, extracted from the culture medium as well as from the dormant cells, were concluded to be a mixture of free coproporphyrin III and uroporphyrin III and their corresponding methyl esters. A possible significance of porphyrin pigment accumulation in the dormant cells is discussed.

17 May 2021 in Applied Microbiology and Biotechnology
Verified
Journal Article
Closed access
PDF file
MSMargarita Shleeva
Margarita Shleeva
ASAlexander Savitsky
Alexander Savitsky
AKArseny Kaprelyants
Arseny Kaprelyants

15 November 2024 in Advanced Drug Delivery Reviews
Verified
Journal Article
Closed access
MSMargarita Shleeva
Margarita Shleeva
GDGalina R. Demina
Galina R. Demina
ASAlexander P. Savitsky
Alexander P. Savitsky

14 April 2012 in Biochemistry (Moscow)
Verified
Journal Article
Closed access
PDF file
VAV. Yu. Artsatbanov
V. Yu. Artsatbanov
GVG. N. Vostroknutova
G. N. Vostroknutova
MSMargarita Shleeva
Margarita Shleeva
AGAnna V. Goncharenko
Anna V. Goncharenko
AZAlexander Zinin
Alexander Zinin
AKA. S. Kapreliants
A. S. Kapreliants
Artificial generation of oxygen superoxide radicals in actively growing cultures of Mycobacterium tuberculosis, Myc. smegmatis, and Corynebacterium ammoniagenes is followed by accumulation in the bacterial cells of substantial amounts of 2-C-methyl-D-erythritol-2,4-cyclodiphosphate (MEcDP) — an intermediate of the non-mevalonate pathway of isoprenoid biosynthesis (MEP) — most possibly due to the interaction of the oxygen radicals with the 4Fe-4S group in the active center and inhibition of the enzyme (E)-4-oxy-3-methylbut-2-enyl diphosphate synthase (IspG). Cadmium ions known to inhibit IspG enzyme in chloroplasts (Rivasseau, C., Seemann, M., Boisson, A. M., Streb, P., Gout, E., Douce, R., Rohmer, M., and Bligny, R. (2009) Plant Cell Environ., 32, 82–92), when added to culture of Myc. smegmatis, substantially increase accumulation of MEcDP induced by oxidative stress with no accumulation of other organic phosphate intermediates in the cell. Corynebacterium ammoniagenes, well-known for its ability to synthesize large amounts of MEcDP, was also shown to accumulate this unique cyclodiphosphate in actively growing culture when NO at low concentration is artificially generated in the medium. A possible role of the MEP-pathway of isoprenoid biosynthesis and a role of its central intermediate MEcDP in bacterial response to nitrosative and oxidative stress is discussed.

17 August 2017 in Frontiers in Cellular and Infection Microbiology
Verified
Journal Article
Open access
MSMargarita Shleeva
Margarita Shleeva
TKTatyana K. Kondratieva
Tatyana K. Kondratieva
GDGalina R. Demina
Galina R. Demina
ERElvira I. Rubakova
Elvira I. Rubakova
AGAnna V. Goncharenko
Anna V. Goncharenko
AKArseny S. Kaprelyants
Arseny S. Kaprelyants
Earlier we demonstrated that the adenylyl cyclase (AC) encoded by the MSMEG_4279 gene plays a key role in growth resuscitation of dormant Mycobacterium smegmatis and that overexpression of this gene resulted in intracellular cAMP concentration increase preventing transition of M. smegmatis from active growth to dormant state in prolonged stationary phase accompanied by medium acidification. We surmised that the homologous Rv2212 gene of M. tuberculosis (Mtb), the main cAMP producer, plays similar physiological roles, supporting the active state under such conditions and reactivation of dormant bacteria. To test this hypothesis, we established Mtb strain overexpressing Rv2212 and compared its in vitro and in vivo growth characteristics with the control strain. In vitro, AC-overexpressing pMindRv2212 strain demonstrated faster growth in liquid medium, prolonged capacity to form CFUs and significant delay or even prevention in transition towards dormancy. AC-overexpressing cells exhibited easier recovery from dormancy. In vivo, AC-overexpressing bacteria demonstrated significantly higher growth rates (virulence) in the lungs and spleens of infected mice compared to the control strain, and, unlike the latter, killed mice of TB-resistant strain before month 8 of infection. Even in the absence of selecting hygromycin B, all pMindRv2212 CFUs retained the Rv2212 insert during in vivo growth, strongly suggesting that AC overexpression is beneficial for bacteria. Taken together, our results indicate that cAMP controls maintenance of Mtb cells vitality under unfavorable conditions in vitro and virulence in vivo.